Guidelines: AIOM Guidelines Compilation (Italy): Difference between revisions
m (Victor moved page Compilation: AIOM Guidelines (Italy) to Guidelines: AIOM Guidelines Compilation(Italy)) |
m (Update categories.) |
||
| Line 108: | Line 108: | ||
<span style="display:none">availableVariable::year</span> | <span style="display:none">availableVariable::year</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">isPracticeGuideline</span> | |||
Revision as of 16:43, 4 December 2025
Go back to Italy page
Primary purpose: To improve and standardize clinical practice, offer the best care to patients nationwide, and provide evidence-based reference for national and regional institutions, regulatory bodies, and payers, with a focus on oncology and pain therapy in cancer patients.
Sponsor, manager or home institution: Associazione Italiana di Oncologia Medica (AIOM).
Type of information: diagnosis, primary tumour localization, tumour histology, tumour staging, comorbidities, risk of cancer, medical procedures, screening, palliative care, year.
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Access to information: Click here to access.